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Free radical production and oxidative stress are known to increase in liver during aging, and may contribute to the oxidative
damage. These changes increase during menopausal condition in females when the level of estradiol is decreased. The objective of
thisstudywastoobservethechangesinactivitiesofmembranelinkedATPases(Na+K+ ATPase, Ca2+ ATPase),antioxidantenzymes
(superoxide dismutase, glutathione-S-transferase), lipid peroxidation levels, lipofuscin content and membrane ﬂuidity occurring
in livers of female rats of 3, 12 and 24 months age groups, and to see whether these changes are restored to 3 months control levels
rats after exogenous administration of 17-β-estradiol (E2). The aged rats (12 and 24 months) were given subcutaneous injection of
E2 (0.1μg/g body weight) daily for one month. The results obtained in the present work revealed that normal aging was associated
with signiﬁcant decrease in the activities of membrane linked ATPases, antioxidant enzymes, membrane ﬂuidity and an increase
in lipid peroxidation and lipofuscin content in livers of aging female rats. The present study showed that E2 treatment reversed the
changes to normal levels. E2 treatment may be beneﬁcial in preventing some of the age related changes in the liver by increasing
antioxidant defenses.
1.Introduction
Free radical production and oxidative stress are known to
increase in liver during aging and may contribute to the
oxidative damage, which plays an important role in the
aging process [1]. Oxidative stress has been implicated in
the pathogenesis of severalalterations due to menopause and
canarise through the increasedproduction oflipid peroxides
and/or a deﬁciency of antioxidant defense [2, 3].
Recently, there has been a growing interest in the actions
and functions of the estrogen replacement therapy and
steroid hormone estrogens (17-β-estradiol, E2) important
role in the progression of chronic hepatic diseases and
synaptic plasticity [4, 5]. Moorthy et al. [6] reported that
older women might also beneﬁt from the protective eﬀects
of hormone replacement therapy (HRT) that uses a relatively
lower concentration of hormones. E2 could enhance antiox-
idant and antiapoptotic activity in hepatic ﬁbrosis in rats
[7, 8].
Morphofunctional studies suggest that the liver, com-
pared with other organs, ages fairly well [9]. Superoxide
dismutase (SOD), which decreased in rat liver, brain, heart,
kidney, and uterus [10, 11] during aging, constitutes an
importantdefensesystemtoclearupthedetrimentalreactive
oxygen species (ROS) in vivo [2]. Glutathione S-transferases
(GST) belong to a group of multigene and multifunctional
detoxiﬁcation enzymes, which defend cells against a wide
variety of toxic insults from chemicals, metabolites, and
oxidative stress [12]. GST decreased with aging in liver [13],
brain [14], and heart [11].
Oxidative stress is postulated to be one of the most
important mechanisms behind age-related decrease in SOD
and GST activities in aging rats [15, 16]. Accordingly, many
studies in the past attempted to clarify how these enzyme
activities are altered during aging (for review, see [2, 17]).
Na+K+ ATPase and Ca2+ ATPase are transmembranous
enzymes that play an important role in maintaining ionic
homeostasis and physiologic function of the liver [18, 19].2 Journal of Aging Research
Decreased Na+K+ ATPase and Ca2+ ATPase activities in liver
of aging animals aﬀect the signal transduction pathway and
cellular functions, suggested as a contributing factor in the
development of age-related disorders with increase in the
content of lipid peroxidation [20, 21].
Free radicals oxidize polyunsaturated fatty acid leading
to the fact that membrane ﬂuidity decreases with aging,
impairing the crucial membrane functions of transport and
permeability [22, 23]. Malondialdehyde (MDA) is one of the
end products in the lipid peroxidation process which leads
to increase in phospholipids rigidity [24]. Lipofuscin is an
autoﬂuorescent pigment that accumulates inside aging tissue
due to increased oxidative stress which represents an end
product of oxidative degradation of lipids [25, 26]. Kumar
et al. [27, 28] had shown that lipofuscin is a peroxidation
product, and its formation appears to be proportional to the
occurrence of lipid peroxidation.
The aim of the present study was to investigate the
antiaging and protective potential of lower doses of E2
than HRT levels treatment on activities of membrane-linked
ATPases (Na+K+ ATPase,Ca2+ ATPase),antioxidantenzymes
(SOD, GST), lipid peroxidation levels, lipofuscin content,
and membrane ﬂuidity in the liver of aging female rats.
2.MaterialsandMethods
2.1. Animals. Female albino rats of the Wistar strain of
diﬀerent ages namely 3, 12, and 24 months (n = 8f o re a c h
group) were used for all the experiments. Animals were
maintained in the animal house facility of Jawaharlal Nehru
University (JNU), New Delhi, India, at a constant temper-
ature of 25◦C, humidity of 55% at 8:00 to 20:00h light,
and 20:00 to 8:00h dark cycle. The animals were fed stand-
ard chow (Hindustan Lever Ltd., India) and given tap
water ad libitum until treatment or time of sacriﬁce. All
the animal procedures were approved by the Institutional
Animal Ethical Committee (IAEC) of Jawaharlal Nehru
University, New Delhi, India
2.2. Hormone Administration. T h ea g e dr a t s( 1 2a n d2 4
monthsold)(n = 8foreachgroup)weregivensubcutaneous
injection of 17-β-estradiol (0.1μg/g body weight) daily
for one month. E2 was dissolved in propylene glycol in
appropriate concentrations [6, 29]. Control animals received
an equal volume of vehicle. There was no treatment on the
day of the sacriﬁce. After 30 days of hormone treatment,
experimental animals of all the groups were sacriﬁced and
livers were isolated for further study.
2.3. Preparation of Homogenates and Subcellular Fractions.
Animals were sacriﬁced by cervical dislocation. Livers were
rapidly excised and washed with chilled normal saline. The
homogenates and subcellular fractions were prepared as
described earlier; the pellet obtained at 12,000g containing
mitochondria and the supernatant fractions were used for
enzyme assays [6, 30]. The pellet was used for determining
Na+K+ ATPase and Ca2+ ATPase activities and membrane
ﬂuidity. Whole homogenates were used for measurement of
lipofuscin and lipid peroxidation. Supernatant fraction was
used for estimation of GST and SOD activities.
2.4. Measurements of Enzymes
2.4.1. Assay of SOD (EC: 1.15.1.1). The activity of SOD was
determined by the method of S. Marklund and G. Marklund
[31], using inhibition of pyrogallol autooxidation at Ph8.0.
T h es p e c i ﬁ ca c t i v i t yo fS O Di se x p r e s s e da su n i t sp e rm g
protein per minute.
2.4.2. Assay of GST (EC: 2.5.1.1.8). The speciﬁc activity
of cytosolic GST was determined spectrophotometrically at
37◦C as described by Gupta et al. [32]. The reaction mixture
(1mL) contained ﬁnal concentration of 0.1M phosphate
buﬀer (pH6.5), 1mM CDNB in 95% ethanol, and 1mM
GSH and was incubated at 37◦C for 5min. The speciﬁc
activity of GST is expressed in terms of micromoles of GSH-
CDNB conjugate formed/min/mg protein.
2.4.3. Assay of Na+K+ ATPase (E.C: 3.6.1.37). Na+K+ ATPase
activity was measured in the pellet according to the method
of Mayanil et al. [33]. The enzyme activity was calculated as
the diﬀerence of the activity between total ATPase and Mg2+
ATPase. The speciﬁc activity of the enzyme is expressed as
μmol Pi released/mg protein/min.
2.4.4. Assay of Ca2+ ATPase (EC: 3.6.3.8). Ca2+ ATPase activ-
ity was measured in the pellet, using a colorimetric method
described by Desaiah et al. [34]. The pellet (∼50μgm i t o -
chondrial protein) was incubated in the reaction medium
of ﬁnal volume 1mL. The speciﬁc activity of the enzyme is
expressed as μmole Pi released/mg protein/min.
2.5. Measurement of Lipid Peroxidation. The formation of
lipid peroxides was measured in the homogenates of the
w h o l el i v e r .T h ef o r m a t i o no fM D A ,a ne n dp r o d u c to ff a t t y
acid peroxidation was measured spectrophotometrically at
532nm by using a thiobarbituric acid reactive substance
(TBARS) essentially by the method of Genet et al. [35].
Results are expressed as nmole of MDA formed/mg protein.
2.6. Lipofuscin Content. The extraction of lipofuscin and
measurement of its ﬂuorescence were essentially as described
by Tappel et al. [36]. Using a primary ﬁlter (366nm)
for excitation and a secondary ﬁlter for emission (485
nm) ﬂuorescence measurements were carried out using
a SLM 4800 model spectroﬂourometer. Quinine sulphate
(0.1μg/mL) in 0.05MH2SO4 was used as a standard. The
results were expressed as percentage ﬂuorescence of control
from 1 mL of homogenate (w/v).
2.7. Membrane Fluidity. The pellets were labelled with 1,6-
diphenyl-1, 3, 5-hexatriene (DPH), a ﬂuorescent probe
by incubating equal volume of the suspension containing
100μg·mL−1 of protein in phosphate buﬀer and 2μMD P H
suspension in the same buﬀer. Excitation and emission
wavelengths were, respectively, 365 and 428nm. PolarizationJournal of Aging Research 3
(P) and anisotropy (r)m e a s u r e m e n t sw e r ec a r r i e do u t
on a model SLM 4800 polarization spectroﬂourometer as
described by Kumar et al. [29].
2.8. Protein Estimation. P r o t e i nw a se s t i m a t e di ns u b c e l l u l a r
fractionsbythemethodofBradford[37]usingbovineserum
albumin (BSA) as standard.
2.9. Statistical Analysis. Results were analyzed using Prism
5.0 (GraphPad, San Diego, Calif, USA). The values are
expressed as mean ± SEM of 4–6 separate values. The data
were analyzed using one-way ANOVA followed by Turkey-
Kramer multiple comparison test to determine the statistical
signiﬁcance. The signiﬁcance was calculated by comparing
the age-matched controls with experimental groups.
2.10.Chemicals. Allpuriﬁedenzymes,coenzymes,substrates,
standards, and buﬀers were from Sigma Chemicals Com-
pany, USA. All other chemicals were of analytical grade and
purchased from SRL and Qualigens, India.
3. Results
3.1. Eﬀect of E2 on General Physiological Parameters in Aging.
An increase in body weight throughout the study was
observed with aging in all the groups. The body weights of
the aging animals increased signiﬁcantly (P<0.05) at 12 and
(P<0.001) in 24 months when compared with 3-month
control rats. There was a signiﬁcant decrease (P<0.05)
with E2 treatment in 24-month age groups when compared
withrespectivecontrols.Therewerenosigniﬁcantchangesin
body weight at 12- and 24-month E2 treatment groups when
compared with 3-month control rats. The protein content in
thewholehomogenates,supernatant,andpelletfractionsdid
not show signiﬁcant changes with aging and E2 treatment.
Results are shown in the Table 1.
3.2. Eﬀect of E2 on Antioxidant Status in Aging. Changes in
theactivitiesofSODandGSTincytosolicfractionsinliverof
3,12,and24-monthcontrolandE2-treatedagingfemalerats
are summarized in Figure 1. With aging there was a decrease
in SOD activity compared to 3-month control animals. In
24-month control group a signiﬁcant (P<0.01) decrease
w a ss e e ni nS O Da c t i v i t yw h e nc o m p a r e dw i t h3 - m o n t h
controls. Treatment of E2 to aging animals increased SOD
activityin12and24months,whencomparedwithrespective
age-matched controls. There was no signiﬁcant change in
SODactivityat12-and24-monthE2treatmentgroupswhen
compared with 3-month controls.
With aging there was a decrease in GST activity as
compared to 3-month control animals. In 24 months there
was a signiﬁcant (P<0.05) decrease in GST activity when
compared with 3-month controls. When compared with
respective age control group, an increased GST activity at
12- and 24-month E2-treated animals was seen. Treatment
withE2toagingratsrestoredtheantioxidantenzymeactivity
nearly to 3-month controls. There was no signiﬁcant change
in GST activity at 12- and 24-month E2 treatment groups
when compared with 3-month control rats.
3.3. Eﬀect of E2 on Membrane-Linked ATPases in Aging.
Changes in the activities of Na+K+ ATPase and Ca2+ ATPase
in pellet fractions of 3, 12, and 24-month control and
E2-treated aging female rats are summarized in Figure 2.
With aging there was a decrease in Na+K+ ATPase activity
as compared to 3-month controls. In 12- and 24-month
control group, there was a signiﬁcant (P<0.05) and (P<
0.001) decrease in Na+K+ ATPase activity when compared
with 3-month controls, respectively. When compared with
respective age controls group, there was no signiﬁcant
changes in 12-month E2-treated animals. In 24-month aged
rats Na+K+ ATPase activity increased signiﬁcant after the E2
treatments (P<0.001) when compared with respective age-
matched controls. There was no signiﬁcant change in Na+K+
ATPase activity at 12- and 24-month E2 treatment groups
when compared with 3-month control rats.
With aging there was a decrease in Ca2+ ATPase activity
ascomparedto3-monthcontrolanimals.In24monthsthere
wasasigniﬁcant(P<0.001)decreaseinCa2+ ATPase activity
when compared with 3-month controls. When compared
with respective age controls, there was no signiﬁcant change
in 12-month E2-treated animals. In 24-month aged rats
Ca2+ ATPase activity increased after the E2 treatments (P<
0.01) as compared to age-matched controls. There was no
signiﬁcant change in Ca2+ ATPase activity at 12- and 24-
month E2 treatment groups when compared with 3-month
rats.TreatmentwithE2inagingratsrestoredthemembrane-
linked ATPases activities nearly to 3-month controls.
3.4. Eﬀect of E2 on Membrane Lipid Peroxidation in Aging.
Lipid peroxidation was measured as the formation of MDA
in whole homogenates of aging rat liver from control and
E2-treated aging animals. With aging there was signiﬁcant
increase (P<0.001) in MDA levels at 12- and 24-month
age groups as compared to the 3-month control animals.
For E2 treatment, to 12 and 24 months old, the MDA levels
decreased signiﬁcantly (P<0.001) at 12 months and (P<
0.001) in 24-month rats, respectively, when compared with
age-matched controls. There was a signiﬁcant (P<0.001)
change in MDA levels at 12- and 24-month E2 treatment
groupswhencomparedwith3months.AdministrationofE2
restored the MDA levels nearly to 3-month controls. Results
are shown in Figure 3(a).
3.5. Eﬀect of E2 on Lipofuscin Content in Aging. Lipofuscin
content was measured in whole homogenates of aging rat
liver of control and E2-treated aging animals. With age there
was signiﬁcant increase (P<0.001) in lipofuscin content
at 24 months as compared to the 3-month control animals.
Administration of E2 treatment decreased lipofuscin content
in 24 months, respectively, as compared to the age-matched
controls (P<0.01). There was no signiﬁcant change in
lipofuscin content at 12- and 24-month E2 treatment groups
when compared with 3-month control rats. Results are
shown in Figure 3(b).4 Journal of Aging Research
Table 1: Body weight and protein concentration of 3, 12, and 24 months of control (C) and estradiol- (E2-) treated aging female rats.
Age/treatment Body wt. (g) Protein content (mg/g)
Whole homogenate Supernatant Mitochondria
3m o n t h s
C 218 ±23 168 ±17.3 129 ±9.31 7 .9 ±1.6
12 months
C 330 ±18
∗ 160 ±18.5 110 ±4.91 9 .5 ±2.1
E2 243 ±27 164 ±7.9 118 ±8.62 0 .8 ±2.7
24 months
C 425 ±36$ 156 ±13.6 108 ±7.41 7 .2 ±1.4
E2 292 ±28c 162 ±8.3 120 ±4.51 8 .6 ±1.2
Each value is a mean ± SEM of ﬁve or more separate values from two to three experiments. The comparisons of experimental values are with the control
values. Statistical signiﬁcance: cP < 0.05 comparing age-matched controls versus E2 treatment and $P<0.001,∗P< 0.05 versus 3 months.
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Figure 1: Changes in the activities of antioxidant enzymes (a) superoxide dismutase (SOD) and (b) glutathione S-transferase (GST) in liver
supernatant fraction of 3, 12, and 24 months of control (C) and estradiol- (E2-) treated aging female rats. Each value is a mean ± SEM of
ﬁve or more separate values from two to three experiments. The comparisons of experimental values are with the control values. Statistical
signiﬁcance: #P<0.01, ∗P<0.05 versus 3 months.
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Figure 2: Changes in the activities of membrane-linked ATPase (a) Na+K+ ATPase and (b) Ca2+ ATPase in liver mitochondria of 3, 12, and
24 months of control (C) and estradiol- (E2-) treated aging female rats. Each value is a mean ± SEM of ﬁve or more separate values from
two to three experiments. The comparisons of experimental values are with the control values. Statistical signiﬁcance: aP<0.001, bP<0.01
comparing age-matched controls versus E2 treatment and $P<0.001,∗P<0.05 versus 3 months.
3.6. Eﬀect of E2 on Membrane Fluidity in Aging. The DPH
ﬂuorescence polarization (P) and anisotropy (r)v a l u e sw e r e
found to increase (P<0.001) in the liver pellet with aging,
reﬂecting a decrease in the probe mobility and an increase
in membrane structural order or a decrease in membrane
ﬂuidity. The membrane ﬂuidity is inversely related to the
anisotropy and polarization parameters. The changes in
ﬂuidity measured in control and E2-treated animals of
diﬀerent age groups showed signiﬁcant decrease in ﬂuidity
with increasing age from 3 months to 24 months. Twelve andJournal of Aging Research 5
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Figure 3: Changes in lipid peroxidation (a) and lipofuscin content (b) in liver of 3, 12, and 24 months of control (C) and estradiol- (E2-)
treated aging female rats. Each value is a mean ± SEM of ﬁve or more separate values from two to three experiments. The comparisons of
experimental values are with the control values. Statistical signiﬁcance: aP < 0.001, bP < 0.01 comparing age-matched controls versus E2
treatment and $P<0.001 versus 3 months.
24-month E2-treated groups elicited a signiﬁcant (P<0.01)
and (P<0.001) decrease in anisotropy as compared to
the respective controls. There was a signiﬁcant (P<0.01)
increase in polarization values at 12-month E2 treatment
groups when compared with 3-month control rats. Results
are presented in Table 2.
4. Discussion
Free radical production and oxidative stress are known to
increase during aging and may contribute to the oxidative
damage, which plays an important role in the aging process
[1]. The impairment of liver metabolism and its gross archi-
tecture, during aging, ﬁnally leads to liver cell death [9]. Age-
related changes in liver may have important implications for
systemic immune responses and hepatic function [38]. Liver
tissuehas thehighest population of macrophagesin the body
andthereforehasagreatpotentialforproducinglocaland/or
systemic inﬂammatory responses [39]. Recently Kireev et
al. [40] had demonstrated that aging produced signiﬁcantly
increased levels of the proinﬂammatory cytokines TNF-
a, IL-1b, and IL-6, whereas the anti-inﬂammatory IL-10
showed a decrease in liver homogenates of old female rats.
Administration of the E2 treatment inhibits the induction of
proinﬂammatory cytokines and iNOS, decreasing the levels
of oxidative stress markers [41].
Thepresentstudyelucidatedtheantiagingandprotective
potential of E2 treatment on activities of membrane-linked
ATPases (Na+K+ ATPase, Ca2+ATPase), antioxidant enzymes
(SOD, GST), lipid peroxidation levels, lipofuscin content,
and membrane ﬂuidity in the livers of aging female rats. Ear-
lier data from our laboratory showed decreased levels of E2
at 12 and 24 months as compared to the 3-month cyclic rats
[10]. The body weight of the female rats increased with age,
primarily due to the increased amount of adipose tissue in
theagedrats.Asigniﬁcantdecreaseinbodyweightwasfound
with E2 treatment, which could be due to the antiobesity
action of E2 [6]. The liver weights were also increased with
Table 2: Changes in polarization and anisotropy measurements in
liver of 3, 12, and 24 months of control (C) and estradiol- (E2-)
treated aging female rats.
Age/treatment Membrane ﬂuidity
Polarization (P) Anisotropy (r)
3m o n t h s
C0 .170 ±0.002 0.157 ± 0.002
12 months
C0 .208 ±0.003$ 0.195 ±0.003$
E2 0.195 ±0.002# 0.172 ±0.004b
24 months
C0 .224 ±0.008$ 0.203 ±0.005$
E2 0.179 ± 0.002a 0.161 ±0.008a
Each value is a mean ± SEM of ﬁve or more separate values from two to
three experiments. The comparisons of experimental values are with the
control values. Statistical signiﬁcance: aP < 0.001, bP < 0.01 comparing age
matched controls versus E2 treatment and $P<0.001,#P<0.01 versus 3
months.
age when compared to control (3 months old) animals. After
theE2treatmenttheliverweightwasincreased.Thisincrease
may be due to increased level of protein content in the liver
(data not shown). Protein content of the hormone-treated
rats which increased signiﬁcantly in liver may be due to
decreased protein catabolism and increased protein synthesis
and also due to decreased gluconeogenesis [6, 25].
The present study reiterates the age-related decline in
activities of antioxidant enzymes in aging liver. Present data
showed that SOD activity decreased signiﬁcantly in liver
of aged animals, agreeing with earlier reports [10, 16, 42];
results also show a parallel decline in GST activity with aging
[20, 43]. E2 treatment to aging rats, which restored SOD
and GST activities, may be due to a decrease in free radicals
generation by E2 and increased in antioxidant defenses [5,
44]. Kireev et al. [45] showed that ovariectomy decreased
GST activity, increased mitochondrial damage in liver, and6 Journal of Aging Research
these changes were improved by E2 administration. Several
studies by the group of Vi˜ na et al. [46, 47] showed the role
of E2 in diﬀerent organs, including liver. Estrogen admin-
istration regulates the expression of antioxidant, longevity-
related genes, and consequently oxidant levels in aging
animals.Estrogensmodulatetheantioxidantgeneexpression
via the transcription factor as NF-kB. Estrogens upregulate
mitochondrial antioxidant genes in females, leading to a
lower mitochondrial oxygen radical generation, and help in
longer longevity of females versus males in Wistar rats [48].
Na+K+ ATPase activity decreased signiﬁcantly in liver
mitochondria of aged animals when compared to 3-month
control animals. This is in agreement with earlier studies
[20, 42]. The decrease in Na+K+ ATPase could be due to
increased oxidative stress and ROS formation with aging
leadingtoincreasedlipidperoxidationandfurtherdamageto
membrane structure. E2 treatment to aging animals restored
the Na+K+ ATPase activity to almost control levels. E2 may
be acting as a radical scavengers by decreasing ROS in aged
rats and maintain the ﬂuidity [4, 49]. In the present study,
Ca2+ ATPaseactivitydecreasedinlivermitochondriaofaging
rats when compared with 3-month controls. The decreased
Ca2+ ATPase activity may lead to increase in intracellular
Ca2+ levels, alter the cellular ﬂuidity, and eventually result
in cell death [36]. E2 treatment to aging rats prevented
the decreased Ca2+ ATPase activity, also decreased oxidative
stress and ROS in aged rats, and restored the membrane
ﬂuidity. E2 increased membrane-linked ATPases; perhaps E2
acts as an endogenous modulator of ATPases and attenuates
the impact of age-related Ca2+ dyshomeostasis [10, 49].
With aging there is signiﬁcant increase in lipid perox-
idation at 12- and 24-month old rats as compared to 3-
month controls. Ample evidence showed that peroxidative
damage to lipid and protein occurs with the aging process
and that the products of these reactions accumulate with age
[2, 27, 28, 50, 51]. Aging rats treated with E2 reversed the
MDA levels to almost normal levels in the liver, suggesting
its anti-lipidperoxidative abilities [8, 49]. Lipofuscin is a
peroxidation product, and its formation appears to be
integrative and proportional to the occurrence of lipid
peroxidation. An age-related increase in lipid peroxidation
has been shown to correlate with the gross level of lipofuscin
[49]. E2 treatment to aging animals showed a decrease in
lipofuscin content in liver [4, 29, 52].
Present results showed the age-dependent reduction
of membrane ﬂuidity [29, 53]. The treatment of aging
animals with E2 reverted the membrane ﬂuidity to normal
level as compared to untreated age-matched controls. E2
treatment decreased free radicals formation and decreased
lipid peroxidation levels, which further improves membrane
ﬂuidity [54]. Estrogen has been known to function as a
radical scavenger inhibiting lipid peroxidation in vivo and in
vitro [2, 10, 29].
E2’s beneﬁcial eﬀects seemed to arise from its biochem-
ical and metabolic eﬀects as an antioxidant and protective
role. It can therefore be concluded that age-related eﬀects
by estrogen hold great promise for improving the clinical
management of selected age-related diseases and metabolic
syndrome.
Abbreviations
E2: 17-β-estradiol,
GST: glutathione S-transferases,
HRT: hormone replacement therapy,
MDA: Malondialdehyde,
ROS: reactive oxygen species,
SOD: superoxide dismutase.
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